| 1. | | Recruiting | Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With Chronic Lymphocytic Leukemia
Conditions: B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ... |
| 2. | | Recruiting | LMB-2 Immunotoxin in Treating Patients With Chronic Lymphocytic Leukemia
Conditions: refractory chronic lymphocytic leukemia; stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ... |
| 3. | | Recruiting | Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
Conditions: stage III chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia; ... |
| 4. | | Recruiting | Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
Conditions: stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; ... |
| 5. | | Recruiting | Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia
Conditions: stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; ... |
| 6. | | Recruiting | Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
Conditions: stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; ... |
| 7. | | Recruiting | Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia
Conditions: B-cell Chronic Lymphocytic Leukemia; stage I cutaneous T-cell lymphoma; stage I mycosis fungoides/Sezary syndrome; ... |
| 8. | | Recruiting | Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia
Conditions: stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia |
| 9. | | Recruiting | Flavopiridol, Fludarabine, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; Hairy Cell Leukemia |
| 10. | | Recruiting | Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia |
| 11. | | Recruiting | Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
Conditions: Anemia; Chronic Lymphocytic Leukemia; Neutropenia; Thrombocytopenia |
| 12. | | Recruiting | Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 13. | | Recruiting | Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies
Conditions: Leukemia, Lymphocytic, Chronic; Leukemia, Lymphocytic, Acute; Lymphoma, Low-Grade; Lymphoma, T-Cell; Lymphoma, B-Cell |
| 14. | | Recruiting | CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 15. | | Recruiting | Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 16. | | Recruiting | Monoclonal Antibody Therapy in Treating Patients With Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia
Conditions: AIDS-related peripheral and systemic lymphoma; adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; ... |
| 17. | | Recruiting | Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma; Prolymphocytic Leukemia; ... |
| 18. | | Not yet recruiting | FR901228 and Rituximab in Treating Patients With Previously Treated B-Cell Chronic Lymphocytic Leukemia
Conditions: B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia |
| 19. | | Recruiting | Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia
Conditions: refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia |
| 20. | | Recruiting | Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia
Conditions: B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia |
| 21. | | Not yet recruiting | Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Conditions: refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia |
| 22. | | Recruiting | HuMax-CD20 in Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia |
| 23. | | Recruiting | Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders
Condition: Chronic Lymphocytic Leukemia |
| 24. | | Recruiting | Allo Transplantation with Mylotarg, fludarabine and melphalan for AML, CML and MDS.
Conditions: Acute Myelogenous Leukemia; Myelodysplastic Syndrome; Chronic Lymphocytic Leukemia |
| 25. | | Recruiting | A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies
Conditions: Peripheral T-Cell Lymphoma; Cutaneous T-Cell Lymphoma; Chronic Lymphocytic Leukemia |
| 26. | | Recruiting | Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia |
| 27. | | Recruiting | Phase I Study of BL22, A Recombinant Immunotoxin for Chronic Lymphocytic Leukemia and CD22+ Lymphomas
Conditions: B Cell Leukemia; Lymphoma; Chronic Lymphocytic Leukemia |
| 28. | | Recruiting | Study of Weekly Clofarabine for Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Condition: Chronic Lymphocytic Leukemia |
| 29. | | Recruiting | Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 30. | | Not yet recruiting | Rituximab and Fludarabine Followed by Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Chronic Lymphocytic Leukemia or Non-Hodgkin's Lymphoma
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 31. | | Recruiting | Tipifarnib in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma; ... |
| 32. | | Recruiting | Bortezomib and Fludarabine in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 33. | | Recruiting | Bortezomib in Treating Patients With Lymphoproliferative Disorders
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 34. | | Recruiting | Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Lymphoma
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia |
| 35. | | Recruiting | Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 36. | | Recruiting | Bone Marrow Transplantation Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer
Conditions: Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; atypical chronic myeloid leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; ... |
| 37. | | Not yet recruiting | FR901228 in Treating Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Acute Myeloid Leukemia
Conditions: adult acute myeloid leukemia; refractory chronic lymphocytic leukemia; Small Lymphocytic Lymphoma |
| 38. | | Recruiting | Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: adult acute myeloid leukemia; refractory chronic lymphocytic leukemia; Small Lymphocytic Lymphoma |
| 39. | | Recruiting | A Pilot Study of Pivanex in Patients with Chronic Lymphocytic Leukemia
Conditions: Leukemia, Lymphocytic, Chronic; Lymphoma, Small Lymphocytic |
| 40. | | Recruiting | Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL)
Condition: Leukemia, Lymphocytic, Chronic |
| 41. | | Recruiting | Safety and Efficacy of IDEC-152 in the Treatment of Chronic Lymphocytic Leukemia (CLL)
Condition: Leukemia, Lymphocytic, Chronic |
| 42. | | Recruiting | Rituximab/Fludarabine/Cyclophosphamide (FCR) versus Fludarabine/Cyclophosphamide (FC) Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL)
Condition: Chronic Lymphocytic Leukemia |
| 43. | | Recruiting | Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
Condition: Chronic Lymphocytic Leukemia |
| 44. | | Recruiting | Genasense™ (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects with Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia |
| 45. | | Recruiting | Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients
Condition: Chronic Lymphocytic Leukemia |
| 46. | | Recruiting | Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies
Conditions: Lymphoma; Chronic Lymphocytic Leukemia |
| 47. | | Recruiting | Megadose CD34 Selected Progenitor Cells for Transplantation in Patients with Advanced Hematological Malignant Diseases
Conditions: Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Myelodysplastic Syndrome; Chronic Lymphocytic Leukemia; Non Hodgkin's Lymphoma |
| 48. | | Recruiting | Safety and Efficacy of Campath in Nonmyeloablative Transplantation
Conditions: Non Hodgkin's Lymphoma; Hodgkin's Disease; Chronic Lymphocytic Leukemia |
| 49. | | Recruiting | Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia; CLL |
| 50. | | Recruiting | UCN-01 and Fludarabine to Treat Lymphoma and Leukemia
Conditions: Chronic Lymphocytic Leukemia; Hairy Cell Leukemia; Leukemia; Lymphoma; Waldenstrom Macroglobulinemia |
